GANNEX
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical-stage drug candidates against three different targets โ FASN, THR-ฮฒ, and FXR โ and three combination therapies. Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma.
GANNEX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gannexpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Founder
Official Site Inspections
http://www.gannexpharma.com
- Host name: 47.75.123.183
- IP address: 47.75.123.183
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "Gannex"
Overview_Gannex Pharma
About GANNEX Who are we? Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. (1672.HK), is dedicated to the R&D and commercialization of new drugs in the โฆSee details»
Gannex - Crunchbase Company Profile & Funding
Sub-Organization of . Ascletis . Founded Date 2019; Founders Jinzi Wu; ... Contact Email [email protected]; Gannex is dedicated to the R&D and commercialization of new drugs โฆSee details»
Gannex Pharma Co Ltd. - Drug pipelines, Patents, Clinical trials
Www.gannexpharma.com. Startups | Private Company | 2019 | Zhejiang Sheng, China | < 10 | www.gannexpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational โฆSee details»
Gannex Pharma Co., Ltd. | Reagan-Udall Foundation
To learn more about available clinical trials by Gannex, please visit www.gannexpharma.com, or visit https://clinicaltrials.gov and search by company, disease or medicine. If you have โฆSee details»
Gannex Pharma - Overview, News & Similar companies
Jun 11, 2024 Who is Gannex Pharma. Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. (1672.HK), is dedicated to the R&D and commercialization of new drugs โฆSee details»
2024_Gannex Pharma
Jan 23, 2024 Gannex Announces Poster Presentation Describing Positive Interim 12-Week Results from Ongoing 52-Week Phase II Clinical Trial of Once-Daily ASC41 in Patients with โฆSee details»
Gannex Pharma Co., Ltd. | Expanded Access Navigator
To learn more about available clinical trials by Gannex, please visit www.gannexpharma.com, or visit https://clinicaltrials.gov and search by company, disease or medicine. If you have โฆSee details»
Gannex Pharma - VentureRadar
Website: https://www.gannexpharma.com/ Gannex, a wholly-owned company of Ascletis, is dedicated to the R&D and commercialization of new drugs in the field of NASH.See details»
Gannex Pharma Co Ltd.:Company Profile & Technical โฆ
Gannex is a company that provides Drug candidate, Combination therapy and more. Gannex is headquartered in United States North America. Gannex was founded in 2019. and was โฆSee details»
Gannex Pharma Co Ltd. - Massachusetts Institute of Technology
Mar 12, 2023 Discovery Company profile page for Gannex Pharma Co Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Gannex Pharma | CipherBio
Explore Gannex Pharma's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Partnership - Gannex Pharma
Partnership. Ascletis was established in 2013 and has been listed on the Hong Kong Stock Exchange since 2018 (1672.HK). Ascletis focuses on the R&D and commercialization of novel โฆSee details»
ๅ ่ดน็ๆฐ่ฏๆ ๆฅๆฐๆฎๅบ - ่ฏๅๆฅ่ฏขใ่ฏๅๆฐๆฎๅบใๅป่ฏๆฐๆฎ
BACKGROUND ASC42 is a non-steroidal farnesoid X receptor agonist currently in clinical development for chronic liver diseases, such as nonalcoholic fatty liver disease/nonalcoholic โฆSee details»
Gannex Pharma - Products, Competitors, Financials, Employees ...
Jun 11, 2024 Primary Biliary Cholangitis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, โฆSee details»
Management Team_Gannex Pharma
Management Team_Gannex Pharma is a biotech company developing NASH drugs. Contact us to enroll in a NASH clinical trial.See details»
Gannex Pharma Careers and Employment | Indeed.com
Find out what works well at Gannex Pharma from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and โฆSee details»
Gannex posts midphase data on NASH asset at center of trade โฆ
Jan 2, 2024 Gannex Pharma has taken a peek at phase 2 data on its nonalcoholic steatohepatitis (NASH) prospect. The Ascletis Pharma subsidiary linked the THRฮฒ agonist to โฆSee details»
2023_Gannex Pharma
Feb 1, 2023 Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D 06/11/2023; Gannex Announces the Completion of Patient โฆSee details»
Pipeline - Gannex Pharma
Pipeline_Gannex Pharma is a biotech company developing NASH drugs. Contact us to enroll in a NASH clinical trial.See details»